EMFAT
TECX

Emerald Mutual Fund Advisers Trust’s Tectonic Therapeutic TECX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,158
Closed -$2.9M – 240
2021
Q2 		$2.9M Sell
27,158
-51,836
-66% -$6.14M 0.09% 150
2021
Q1 		$12M Buy
78,994
+1,275
+2% +$207K 0.4% 96
2020
Q4 		$13M Buy
77,719
+18,812
+32% +$3.34M 0.45% 89
2020
Q3 		$9.2M Sell
58,907
-3,491
-6% -$703K 0.41% 78
2020
Q2 		$13.1M Buy
62,398
+2,544
+4% +$524K 0.62% 60
2020
Q1 		$11.2M Buy
59,854
+6,405
+12% +$1.51M 0.7% 51
2019
Q4 		$12.9M Buy
53,449
+10
+0% +$1.93K 0.53% 74
2019
Q3 		$9.05M Buy
53,439
+9,890
+23% +$2.24M 0.4% 93
2019
Q2 		$8.5M Hold
43,549
– – 0.34% 100
2019
Q1 		$11.5M Buy
43,549
+12,477
+40% +$2.28M 0.46% 76
2018
Q4 		$6.21M Buy
31,072
+944
+3% +$288K 0.29% 122
2018
Q3 		$18.8M Buy
30,128
+12,546
+71% +$5.56M 0.63% 51
2018
Q2 		$6.03M Buy
+17,582
New +$6.34M 0.22% 146

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TECX Position: Q3 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 27,158 shares — an estimated $2.9M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TECX in Q2 2018 and held it in 13 quarters. The position peaked at $18.8M in Q3 2018. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Emerald Mutual Fund Advisers Trust reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 27,158 Tectonic Therapeutic shares in Q3 2021, an estimated $2.9M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 13 quarters.
  • Emerald Mutual Fund Advisers Trust's Tectonic Therapeutic position peaked at $18.8M in Q3 2018.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2021, filed 28 Oct 2021.